ConductScience.org, home

Paper3606944

Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours.

Milano G and 9 others. Br J Cancer, 1987. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours. Papers, record 3606944. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3606944

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours.
PubMed
Journal
Br J Cancer
PubMed
Year
1987
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
1.56
iCite
Revised in PubMed
2019-05-15
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Milano GG
2Etienne MCM C
3Frenay MM
4Khater RR
5Formento JLJ L
6Renee NN
7Moll JLJ L
8Francoual MM
9Berto MM
10Namer MM

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
TamoxifenMajor topic
Chromatography, High Pressure Liquid
Cytosol
Female
Humans
Methods

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16542011Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare.Eur J Cancer Clin Oncol1984https://conductscience.org/library/papers/6542011PubMed
26488162Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.Cancer Res1984https://conductscience.org/library/papers/6488162PubMed
33978620Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.Cancer Res1985https://conductscience.org/library/papers/3978620PubMed
44015045Antiestrogen binding sites in human breast cancer biopsies. Measurement ligand-specificity and affinity, and correlation to estrogen and progesterone receptors.Anticancer Res1985https://conductscience.org/library/papers/4015045PubMed
57364914Paired-ion chromatographic analysis of tamoxifen and two major metabolites in plasma.J Chromatogr1980https://conductscience.org/library/papers/7364914PubMed
67427960Studies on the metabolism and pharmacokinetics of tamoxifen in normal volunteers.Cancer Treat Rep1980https://conductscience.org/library/papers/7427960PubMed
77427961Clinical pharmacology of tamoxifen in patients with breast cancer: comparison of traditional and loading dose schedules.Cancer Treat Rep1980https://conductscience.org/library/papers/7427961PubMed
87471314Clinical pharmacology of tamoxifen and N-desmethyltamoxifen in patients with advanced breast cancer.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/7471314PubMed
97227442The binding of tamoxifen to human mammary carcinoma cytosol.Eur J Cancer (1965)1980https://conductscience.org/library/papers/7227442PubMed
107317574
Comparative binding affinities of tamoxifen, 4-hydroxytamoxifen, and desmethyltamoxifen for estrogen receptors isolated from human breast carcinoma: correlation with blood levels in patients with metastatic breast cancer.
Biopharm Drug Dispos1981https://conductscience.org/library/papers/7317574PubMed
117199465Determination of tamoxifen and biologically active metabolites in human breast tumours and plasma.Eur J Cancer Clin Oncol1981https://conductscience.org/library/papers/7199465PubMed
126848356Antiestrogen-binding sites distinct from the estrogen receptor: subecellular localization, ligand specificity, and distribution in tissues of the rat.Endocrinology1983https://conductscience.org/library/papers/6848356PubMed
136870933Identification and biological activity of tamoxifen metabolites in human serum.Biochem Pharmacol1983https://conductscience.org/library/papers/6870933PubMed
146883318Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro.Cancer Res1983https://conductscience.org/library/papers/6883318PubMed
156619251High-performance liquid chromatographic analysis of tamoxifen and major metabolites in human plasma.J Chromatogr1983https://conductscience.org/library/papers/6619251PubMed
166626456Simultaneous micro measurement of steroid receptors in breast cancer.Br J Cancer1983https://conductscience.org/library/papers/6626456PubMed
176685632A comparative study of electrophoretic mobilities of [3H]-estradiol and monohydroxytamoxifen binding components in the cytosols of human breast carcinomas and sera of healthy adult females.Eur J Cancer Clin Oncol1983https://conductscience.org/library/papers/6685632PubMed
186692388Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor.Cancer Res1984https://conductscience.org/library/papers/6692388PubMed
196362856Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration.Cancer Res1984https://conductscience.org/library/papers/6362856PubMed
206420159The measurement of tamoxifen and metabolites in the rat and relationship to the response of DMBA-induced mammary tumours.Eur J Cancer Clin Oncol1984https://conductscience.org/library/papers/6420159PubMed

See all 22 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
17526937Tamoxifen activates CYP3A4 and MDR1 genes through steroid and xenobiotic receptor in breast cancer cells.Endocrine2006https://conductscience.org/library/papers/17526937PubMed
15587933Potential beneficial metabolic interactions between tamoxifen and isoflavones via cytochrome P450-mediated pathways in female rat liver microsomes.Pharm Res2004https://conductscience.org/library/papers/15587933PubMed
3048447The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole.Breast Cancer Res Treat1988https://conductscience.org/library/papers/3048447PubMed
2803912Tamoxifen metabolism: pharmacokinetic and in vitro study.Br J Cancer1989https://conductscience.org/library/papers/2803912PubMed
2736207Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells.Br J Cancer1989https://conductscience.org/library/papers/2736207PubMed
2661195Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.Drugs1989https://conductscience.org/library/papers/2661195PubMed
1505141Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.Clin Pharmacokinet1992https://conductscience.org/library/papers/1505141PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3606944

GET https://conductscience.org/api/papers/v1/3606944/references?page=2